将“财健道”设为星标持续关注,不错过好看每日医刻1司美格鲁肽一季度销量全球第一5月7日,诺和诺德公布2025年一季度业绩,总营收780.87亿丹麦克朗,约112.16亿美元,同比增长18%。司美格鲁肽合计收入569.34亿丹麦克朗,约80.11亿美元,高于礼来的替尔泊肽(61.50亿美元)和默沙东的帕博利珠单抗(72.05亿美元)。这也意味着,司美格鲁肽全球销售额终于超过K药,暂时坐上了全球“药王...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.